Atlas Trials

A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency

Clinical trial NCT05783557 · UNKNOWN

Trial details

NCT number
NCT05783557
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertensive Emergency
Start date
2023-05-01
Primary completion
2024-12-01
Enrollment
398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.